Dr. Morgan joined Perlmutter Cancer Center in February 2019 as director of multiple myeloma research. He previously served as the director of the Myeloma Institute, deputy director of the Winthrop P. Rockefeller Cancer Institute, and professor of hematology at the University of Arkansas for Medical Sciences, where he directed numerous clinical and translational research studies investigating the treatment, genetics and biology of myeloma. He has pioneered studies investigating the genetic basis and treatment of multiple myeloma. He has been a major contributor to the Myeloma Genome Project, a collaboration to segment and individualize therapy for subgroups of the myeloma.